In melanoma cells, it has been shown that a v-Raf murine sarcoma viral oncogene homolog B1 (BRAF)- mitogen-activated protein kinase kinase (MEK) inhibitor agent can induce pyroptosis by triggering GSDME, leading to elevated T-cell infiltration and immune system responses. The gene discussed is BRAF; the disease is melanoma.